Contact
Please use this form to send email to PR contact of this press release:
Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed
TO:
Please use this form to send email to PR contact of this press release:
Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed
TO: